Skip to main content

Hayward Marshall A.'s Form 4 filing

Jupiter Neurosciences, Inc. (JUNS) · filed Jul 13, 2026

Accession no.
0001493152-26-033015
Filed
Jul 13, 2026, 4:00 PM ET
Trade date
Jun 2, 2025-Mar 2, 2026
Filing delay
406 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 3 derivative transactions. It was filed 406 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hayward Marshall A.CIK 0001891872Director, Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 2, 2025Common StockMOption exerciseAcquired+389,793––2,370,675Direct
Jun 2, 2025Common StockMOption exerciseAcquired+399,402––2,770,077Direct
Mar 2, 2026Common StockMOption exerciseAcquired+225,000––2,995,077Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 2, 2025Common StockMOption exerciseDisposed−389,793$0.00$00Direct
Jun 2, 2025Common StockMOption exerciseDisposed−399,402$0.00$00Direct
Mar 2, 2026Common stockMOption exerciseDisposed−225,000$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)